-
Shefer, A, Markowitz, L, Deeks, S, Tam, T, Irwin, K, Garland, SM, Schuchat, A.
Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada and Australia.
Vaccine
26:
k68 -k75
2008
view publication
-
Garland, SM, Brotherton, JML, Skinner, SR, Pitts, M, Saville, M, Mola, G, Jones, RW.
Human Papillomavirus and Cervical Cancer in Australasia and Oceania: Risk-factors, Epidemiology and Prevention.
Vaccine
26:
m80 -m88
2008
view publication
-
SASADEUSZ, JJ, SILVERS, JE, KENT, HE, DEVENISH, W, HOCKING, J, GARLAND, SM.
Prevalence of HSV‐2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital.
Australian and New Zealand Journal of Obstetrics and Gynaecology
48(3)
:
266 -272
2008
view publication
-
Stevens, MP, Tan, SE, Horvath, L, Fairley, CK, Garland, SM, Tabrizi, SN.
Absence of a Chlamydia trachomatis variant, harbouring a deletion in the cryptic plasmid, in clients of a sexually transmissible infection clinic and antenatal patients in Melbourne..
Communicable Diseases Intelligence
32(1)
:
77 -81
2008
view publication
-
Skinner, SR, Garland, SM, Stanley, MA, Pitts, M, Quinn, MA.
Human papillomavirus vaccination for the prevention of cervical neoplasia: is it appropriate to vaccinate women older than 26?.
The Medical Journal of Australia
188(4)
:
238 -242
2008
view publication